NEOS Investment Management LLC Has $10.10 Million Position in Danaher Co. (NYSE:DHR)

NEOS Investment Management LLC boosted its position in Danaher Co. (NYSE:DHR) by 6.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 43,990 shares of the conglomerate’s stock after acquiring an additional 2,778 shares during the quarter. NEOS Investment Management LLC’s holdings in Danaher were worth $10,098,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Sava Infond d.o.o. acquired a new position in shares of Danaher during the 4th quarter worth $744,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Danaher by 7.5% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,023,696 shares of the conglomerate’s stock worth $240,405,000 after acquiring an additional 71,540 shares in the last quarter. Korea Investment CORP lifted its holdings in shares of Danaher by 0.8% in the fourth quarter. Korea Investment CORP now owns 500,750 shares of the conglomerate’s stock worth $114,947,000 after acquiring an additional 3,913 shares during the last quarter. Mendel Money Management boosted its stake in shares of Danaher by 0.8% in the 4th quarter. Mendel Money Management now owns 22,447 shares of the conglomerate’s stock valued at $5,153,000 after purchasing an additional 179 shares in the last quarter. Finally, Banco BTG Pactual S.A. bought a new stake in shares of Danaher during the 4th quarter valued at approximately $771,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Raymond James reissued a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a research report on Friday, December 13th. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a report on Friday, March 14th. Finally, Robert W. Baird dropped their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Five investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $278.24.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

NYSE DHR opened at $210.15 on Thursday. The company has a market capitalization of $150.19 billion, a PE ratio of 39.80, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a 50-day simple moving average of $215.86 and a 200 day simple moving average of $237.56.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the firm posted $2.09 EPS. On average, research analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.61%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is 24.24%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.